Peter Horby to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Peter Horby has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.038
-
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
Score: 0.038